Expression of SGLT1 and SGLT2 in Breast Cancer and Potential Anticancer Effects of SGLT1 Inhibitors

被引：0
|
作者：
Tsunokake, Satoko [1 ]
Iwabichi, Erina [2 ]
Miki, Yasuhiro [3 ]
Kanai, Ayako [4 ]
Onodera, Yoshiaki [3 ]
Ishida, Takanori [1 ]
Sasano, Hironobu [3 ]
Suzuki, Takashi [2 ,3 ,5 ]
机构：
[1] Tohoku Univ, Dept Breast & Endocrine Surg Oncol, Sendai, Miyagi, Japan
[2] Tohoku Univ, Dept Pathol & Histotechnol, Sendai, Miyagi, Japan
[3] Tohoku Univ, Dept Anat Pathol, Sendai, Miyagi, Japan
[4] Hachinohe Municipal Hosp, Dept Breast Surg, Hachinohe, Aomori, Japan
[5] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3266
引用
收藏
页码：1939 / 1939
页数：1
相关论文
共 50 条
  • [31] Investigational Agents Targeting SGLT1 and SGLT2 in the Treatment of Type 2 Diabetes Mellitus
    Cui, Haigang
    Luo, Xin
    Chen, Mingwei
    Lu, Jun
    Liu, Johnson J. J.
    CURRENT DRUG TARGETS, 2023, 24 (08) : 648 - 661
  • [32] Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
    Sands, Arthur T.
    Zambrowicz, Brian P.
    Rosenstock, Julio
    Lapuerta, Pablo
    Bode, Bruce W.
    Garg, Satish K.
    Buse, John B.
    Banks, Phillip
    Heptulla, Rubina
    Rendell, Marc
    Cefalu, William T.
    Strumph, Paul
    DIABETES CARE, 2015, 38 (07) : 1181 - 1188
  • [33] Dual SGLT1 and SGLT2 inhibitor sotagliflozin achieves FDA approval: landmark or landmine?
    Milton Packer
    Nature Cardiovascular Research, 2023, 2 : 705 - 707
  • [34] Biophysical characteristics of the pig kidney Na+/glucose cotransporter SGLT2 reveal a common mechanism for SGLT1 and SGLT2
    Mackenzie, B
    Loo, DDF
    PanayotovaHeiermann, M
    Wright, EM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) : 32678 - 32683
  • [35] Dual SGLT1 and SGLT2 inhibitor sotagliflozin achieves FDA approval: landmark or landmine?
    Packer, Milton
    NATURE CARDIOVASCULAR RESEARCH, 2023, 2 (08): : 705 - 707
  • [36] A Review of the Potential Role of Sotagliflozin: A Dual SGLT2 and SGLT1 Inhibitor-in the Treatment of Heart Failure
    Tran, Bao Anh C.
    White, Raechel T.
    Bullers, Krystal
    Cornelio, Cyrille K.
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (05) : 248 - 256
  • [37] Effects of melatonin and resveratrol on renal expression of sodium-glucose cotransporters SGLT1 and SGLT2 in rat model of aging
    Madunic, I. Vrhovac
    Karaica, D.
    Micek, V.
    Ljubojevic, M.
    Geric, M.
    Gajski, G.
    Rasic, D.
    Peraica, M.
    Orct, T.
    Jurasovic, J.
    Jovanovic, I. Novak
    Nanic, L.
    Rubelj, I.
    Sabolic, I.
    Breljak, D.
    FEBS OPEN BIO, 2018, 8 : 389 - 389
  • [38] Effect of SGLT2 and dual SGLT1/2 Inhibition on the Development of Salt-induced Hypertension
    Levchenko, Vladislav
    Kravtsova, Olha
    Upadhyay, Gunjan
    Bohovyk, Ruslan
    Rieg, Timo
    PHYSIOLOGY, 2024, 39
  • [39] SGLT2 Inhibition Increases Renal Uric Acid Excretion: Evidence from Mice Lacking SGLT2 and Potentiation in the Absence of SGLT1
    Novikov, Aleksandra
    Fu, Yiling
    Patel, Rohit
    Van Ginkel, Charlotte
    Onishi, Akira
    Song, Panai
    Koepsell, Hermann
    Huang, Winnie
    Vallon, Volker
    DIABETES, 2017, 66 : A14 - A14
  • [40] Dual SGLT1/SGLT2 inhibitor phlorizin reduces glucose transport in experimental peritoneal dialysis
    Martus, Giedre
    Bergling, Karin
    Oberg, Carl M.
    PERITONEAL DIALYSIS INTERNATIONAL, 2023, 43 (02): : 145 - 150
12345